Publications on the Use of Glycan Nodes as Diagnostic and/or Prognostic Tools

1. Hu, Y., Ferdosi, S., Kapuruge, E.P., Aguilar Diaz de Leon, J., Stücker, I, Radoï L, Guénel P, Borges, C.R.: Diagnostic and Prognostic Performance of Blood Plasma Glycan Features in the Women Epidemiology Lung Cancer (WELCA) Study. Journal of Proteome Research 18(11): 3985-3998, 2019.
Request a Copy

2. Ferdosi, S., Rehder, D.S., Maranian, P., Castle, E.P., Ho, T.H., Pass, H.I., Cramer, D.W., Anderson, K.S., Fu, L., Cole, D.E.C., Le, T., Wu, X., Borges, C.R.: Stage Dependence, Cell-Origin Independence and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching and α2-6 Sialylation in Cancer. Journal of Proteome Research 17: 543-558, 2018.
Download a Copy

3. Ferdosi, S., Ho, T.H., Castle, E.P., Stanton, M.L., Borges, C.R.: Behavior of blood plasma glycan features in bladder cancer. PloS One, 13(7):e0201208, 2018.
Download a Copy